查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1924633

血庫及血液製品市場依產品類型、應用、最終用戶及技術分類－2026-2032年全球預測

Blood Banking & Blood Products Market by Product Type, Application, End User, Technology - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，血庫和血液製品市場價值將達到 215 億美元，到 2026 年將成長至 231.4 億美元，到 2032 年將達到 392.6 億美元，年複合成長率為 8.98%。

關鍵市場統計數據
基準年 2025 215億美元
預計年份：2026年 231.4億美元
預測年份 2032 392.6億美元
複合年成長率 (%) 8.98%

血液銀行和血液製品產業處於臨床需求、技術創新和複雜供應鏈動態的交匯點。診斷方法、自動化和數據整合的最新進展正在改變血液的收集、檢測、處理、儲存和分發方式，為提高安全性、效率和患者療效創造了新的機會。同時，人口結構的變化、擇期和急診醫療模式的演變以及對輸血傳播感染疾病日益成長的關注，都在持續影響著各醫療機構的運作重點。

本執行摘要提煉了影響該行業的最相關趨勢，並綜合分析了這些趨勢對醫院系統、診斷檢查室和中心血庫等相關人員的影響，同時為製造商、服務供應商和政策顧問提供決策指南。報告重點關注可觀察的趨勢，例如先進血液分離平台的應用、高靈敏度核酸擴增工作流程的出現以及監管和貿易政策變化對運營的影響，強調實用見解而非推測性預測。本報告旨在為領導者提供清晰、實用的觀點，幫助他們設定投資重點、制定籌資策略策略並建立夥伴關係。

技術創新與商業需求如何整合，重塑血液製品生態系統的臨床工作流程與供應鏈韌性

隨著技術、監管和營運因素的融合，血庫和血液製品產業正經歷著變革性的轉變。自動化數位化正從實驗室工作台擴展到端到端的流程協調，從而實現更一致的成分製備和可追溯性。流式細胞技術在專業的免疫血液學應用中日益成熟，核酸擴增技術也因其靈敏的病原體檢測能力而日益普及，這些因素共同提高了安全性和通量標準。

評估關稅變化對血液服務供應鏈、籌資策略和組織韌性的多方面營運和採購影響

關稅及相關貿易措施的實施對整個血庫生態系統產生了顯著的連鎖反應，影響到設備採購、試劑採購以及跨境服務合約的經濟效益。關稅會增加專用設備、自動化分離器和高靈敏度檢測套組的成本，這將影響血庫、醫院和診斷檢查室的採購模式，迫使採購團隊尋找替代供應商或營運補償措施以維持服務水準。

策略性細分分析揭示了產品分類、臨床應用、最終用戶和診斷技術如何相互交織，從而定義產品採納路徑。

對產品層面與應用層面細分的深入理解，有助於明確臨床價值與商業性機會的交會。在產品類型方面，血液分離設備涵蓋白血球分離、血漿分離和血小板分離等多種模式，每種模式都針對特定的治療和採集需求。血液採集和儲存系統包含多種血袋配置，包括單袋、雙袋、三袋和四袋，以滿足不同的血液成分分離需求。血液成分分離設備種類繁多，從可最大限度提高通量和一致性的自動化平台，到在低通量和資源受限環境下仍然效用的手動製備裝置，應有盡有。血液篩檢測試包括儀器平台和試劑/試劑盒，可進一步分為免疫血液學檢測、傳染病篩檢和核酸檢測試劑。輸血設備包括輸注設備和加熱設備，這些設備對於安全輸血至關重要。

區域趨勢和採購環境將決定診斷能力、管理體制和供應鏈如何影響全球市場的接受度。

區域趨勢將對全球血液生態系統的技術應用、監管路徑和供應鏈設計產生深遠影響。在美洲，醫療系統呈現多樣化的採購模式，從集中式的國家項目到分散式的醫院主導採購，不一而足，這塑造了對高通量自動化和適應性強的照護現場的需求。分子診斷和捐血篩檢的進步通常得益於完善的檢查室基礎設施和成熟的報銷機制，從而為先進的核酸增幅檢查（NAT）和流式細胞技術的推廣應用創造了有利環境。

一體化產品服務模式和策略夥伴關係如何重新定義血液製品產業製造商和供應商的競爭優勢

血液銀行和血液製品產業的競爭動態正日益受到整合硬體、耗材和軟體服務的綜合臨床解決方案的影響。領先的製造商正透過將自動化成分分離器和血球分離平台與檢驗的試劑組合以及簡化庫存管理和捐血者追蹤的數位化工具相結合，來強化其價值提案。策略聯盟和有針對性的收購正被用於彌補能力差距、加速進入相鄰應用領域以及加強服務網路。

務實的領導優先事項包括協調採購、互通性、員工發展和來源多樣性，以增強業務連續性。

行業領導者應優先考慮將技術能力與營運韌性和臨床安全要求相結合的投資。首先，應強調籌資策略，在確保長期可維護性和耗材供應的同時，兼顧初始投資效率，確保設備選型得到可靠的售後服務網路和檢驗的試劑供應支持。其次，應選擇支援標準化資料交換和實驗室資訊系統整合的平台和供應商，以促進互通性，從而提高可追溯性並實現更有效的品管。

一種多層次的研究途徑，結合專家對話、監管分析和技術評估，以產生經過實踐驗證且具有實際操作價值的見解。

本研究採用多層次調查方法進行綜合分析，該方法整合了定性專家訪談、公開的監管文件、同行評審的臨床文獻以及主要供應商的技術資料，從而全面了解當前的行業趨勢。研究人員對臨床醫生、實驗室主任、採購專業人員和製造工程師進行了專家訪談，以確定不同營運環境下的實際限制、推廣促進因素和實施經驗教訓。此外，研究人員還分析了公開的監管文件和指導文件，以確定與篩檢和輸血安全相關的合規要求和不斷發展的標準。

綜合結論強調了將技術進步和供應鏈韌性與持續的臨床結果聯繫起來的實際步驟。

目前血庫和血液製品產業既面臨挑戰，也蘊藏著實際機會。診斷靈敏度、自動化和流程整合的進步提高了安全性和效率的標準，而地緣政治和貿易趨勢則凸顯了建立具有韌性的供應鍊和靈活採購模式的必要性。那些積極主動地將技術選擇與可維護性、數據互通性和人員配備相結合的機構，將更有能力在不斷變化的臨床需求面前，維持高品質的輸血服務。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依產品類型分類的血庫和血液製品市場

  • 血液分離機
    • 白血球分離術
    • 等離子分離器
    • 血小板分離術
  • 血液採集和儲存系統
    • 雙血袋
    • 四聯血袋
    • 單血袋
    • 三重血袋
  • 血液成分分離裝置
    • 自動血液成分分離裝置
    • 手動血液成分製備套裝
  • 血液篩檢測試
    • 裝置
    • 試劑和試劑盒
      • 免疫血液學檢測
      • 傳染病篩檢
      • 核酸增幅檢查（NAT）試劑
  • 輸血設備
    • 點滴裝置
    • 加熱裝置

9. 按應用分類的血庫和血液製品市場

  • 免疫血液學
  • 分子診斷
  • 品管

第10章 以最終用戶分類的血庫和血液製品市場

  • 血庫和捐血中心
  • 診斷檢查室
  • 醫院

11. 依技術分類的血庫和血液製品市場

  • 流式細胞技術
  • 核酸擴增技術
  • 血清學檢測

12. 按地區分類的血庫和血液製品市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 按群體分類的血庫和血液製品市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

14. 各國血庫及血液製品市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

15. 美國血庫與血液製品市場

第16章 中國血庫與血液製品市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • American National Red Cross
  • Asahi Kasei Corporation
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Cardinal Health, Inc.
  • CSL Limited
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Fresenius SE & Co. KGaA
  • Greiner Bio-One International GmbH
  • Grifols, SA
  • Haemonetics Corporation
  • Immucor, Inc.
  • Kedrion SpA
  • LFB SA
  • Macopharma SA
  • Medline Industries, Inc.
  • Nipro Corporation
  • Octapharma AG
  • Ortho Clinical Diagnostics, Inc.
  • QIAGEN NV
  • Shandong Weigao Group Medical Polymer Co., Ltd.
  • Takeda Pharmaceutical Company Limited
  • Terumo Corporation
  • Thermo Fisher Scientific Inc.
  • Vitalant, Inc.
Product Code: MRR-7A380DA7C3E8

The Blood Banking & Blood Products Market was valued at USD 21.50 billion in 2025 and is projected to grow to USD 23.14 billion in 2026, with a CAGR of 8.98%, reaching USD 39.26 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 21.50 billion
Estimated Year [2026] USD 23.14 billion
Forecast Year [2032] USD 39.26 billion
CAGR (%) 8.98%

The blood banking and blood products sector sits at the intersection of clinical necessity, technological innovation, and complex supply chain dynamics. Recent advances in diagnostic modalities, automation, and data integration have reshaped how blood is collected, tested, processed, stored, and delivered, creating new opportunities to enhance safety, efficiency, and patient outcomes. At the same time, demographic shifts, evolving patterns of elective and emergency care, and heightened attention to transfusion-transmissible infections continue to influence operational priorities across institutions.

This executive summary distills the most pertinent developments shaping the sector, synthesizes implications for stakeholders across hospital systems, diagnostic laboratories, and centralized blood banks, and highlights decision levers for manufacturers, service providers, and policy advisors. The narrative emphasizes practical insights over speculative projection, focusing on observable trends such as the adoption of advanced apheresis platforms, the emergence of high-sensitivity nucleic acid amplification workflows, and the operational impact of regulatory and trade policy shifts. The goal is to equip leaders with clear, actionable perspectives that support investment prioritization, procurement strategy, and partnership formation.

How converging technological innovations and operational imperatives are reshaping clinical workflows and supply chain resilience across the blood products ecosystem

The landscape of blood banking and blood products is undergoing transformative shifts driven by converging technological, regulatory, and operational forces. Automation and digitalization have expanded beyond laboratory benchtops into end-to-end process orchestration, enabling more consistent component preparation and traceability. Flow cytometry has matured for specialized immunohematology applications while nucleic acid amplification techniques are gaining traction for high-sensitivity pathogen detection, collectively raising the bar for safety and throughput.

Simultaneously, modular and scalable apheresis platforms are enabling blood centers to respond dynamically to changing donor availability and therapeutic demand patterns. The integration of improved reagents and point-of-care immunohematology instruments is reducing turnaround times and enabling decentralized testing models that can relieve pressure on centralized laboratories. In parallel, warming devices and infusion technologies are being refined to support complex transfusion scenarios in ambulatory and inpatient settings.

These technological shifts intersect with operational imperatives. Institutional emphasis on supply chain resilience, inventory optimization, and donor recruitment strategies is prompting investments in collection and storage systems that can accommodate variable demand. As stakeholders implement these innovations, attention to interoperability, data governance, and workforce training becomes critical to translate capability into consistent, measurable improvements in patient care.

Assessing the multifaceted operational and procurement consequences of tariff changes on supply chains, sourcing strategies, and institutional resilience in blood services

The imposition of tariffs and associated trade measures can create substantive ripple effects across the blood banking ecosystem, affecting equipment procurement, reagent sourcing, and the economics of cross-border service arrangements. Tariffs that elevate the cost of specialized instruments, automated separators, and high-sensitivity testing kits influence buying patterns among blood banks, hospitals, and diagnostic laboratories, with procurement teams seeking either alternative suppliers or operational offsets to preserve service levels.

In response to tariff-driven cost pressures, some institutions may extend equipment replacement cycles, defer noncritical upgrades, or consolidate purchasing through group procurement vehicles to maintain access to essential technologies. Others might pursue deeper technical validation of domestic alternatives or prioritize instrument-agnostic reagent portfolios to mitigate exposure. Tariff effects also accelerate conversations about local manufacturing and nearshoring for critical components and consumables, which in turn reshape supplier selection criteria and contract negotiation strategies.

Operationally, increased import costs can heighten the focus on process efficiencies and yield optimization, prompting investments in component separators and collection systems that maximize usable output per donation. Regulatory compliance continues to be a central consideration as institutions balance cost mitigation with the imperative to meet established safety standards. Overall, tariff-related changes amplify the need for flexible procurement strategies, robust supplier risk assessments, and contingency planning to ensure uninterrupted patient services.

Strategic segmentation analysis revealing how product classes, clinical applications, end users, and diagnostic technologies intersect to define adoption pathways

A nuanced understanding of product-level and application-focused segmentation clarifies where clinical value and commercial opportunity converge. Within product types, apheresis equipment spans modalities such as leukapheresis, plasma apheresis, and platelet apheresis, each serving discrete therapeutic and collection priorities; blood collection and storage systems encompass diverse bag configurations including single, double, triple, and quadruple blood bags that respond to component separation needs; blood component separators range from automated platforms that maximize throughput and consistency to manual preparation sets that retain relevance in lower-volume or resource-constrained environments. Blood screening tests comprise instrument platforms and reagents and kits, with reagents further differentiated across immunohematology testing, infectious disease screening, and nucleic acid testing reagents, and blood transfusion equipment incorporates infusion devices and warming devices critical for safe delivery.

Application segmentation delineates contexts of use such as immunohematology, molecular diagnostics, and quality control workflows, where each application imposes distinct technical and regulatory requirements that influence procurement and operational priorities. End user segmentation highlights the different buyer behaviors and operational imperatives of blood banks and donation centers, diagnostic laboratories, and hospitals, each of which balances cost, throughput, and clinical risk in unique ways. Technology segmentation-covering flow cytometry, nucleic acid amplification technology, and serological testing-underscores the importance of aligning platform selection with diagnostic sensitivity, throughput demands, and compatibility with existing laboratory information systems.

Bringing these dimensions together reveals differentiated pathways for adoption and investment. High-throughput automated separators and NAT-capable screening workflows tend to align with centralized blood bank strategies focused on yield and risk mitigation, whereas single or manual collection systems paired with serological testing maintain relevance for decentralized or low-resource settings. Immunohematology solutions that integrate flow cytometry provide advanced antigen profiling capabilities for complex transfusion management, while smaller hospitals may prioritize robust infusion and warming devices to support bedside transfusion safety. The interplay of product type, application, end user, and technology creates a mosaic of requirements that suppliers and purchasers must navigate to optimize clinical outcomes and operational efficiency.

Regional dynamics and procurement environments that determine how diagnostic capabilities, regulatory regimes, and supply chains shape adoption across global markets

Regional dynamics exert a profound influence on technology adoption, regulatory pathways, and supply chain design across the global blood ecosystem. In the Americas, healthcare systems exhibit diverse procurement models spanning centralized national programs to decentralized hospital-driven purchasing, which shapes demand for both high-throughput automation and adaptable point-of-care solutions. Progress in molecular diagnostics and donor screening is often supported by strong laboratory infrastructure and established reimbursement pathways, creating an environment in which advanced NAT and flow cytometry implementations can scale.

Across Europe, the Middle East, and Africa, regulatory heterogeneity and varying investment capacities result in differentiated adoption patterns. Some European markets prioritize harmonized standards and robust pharmacovigilance, encouraging deployment of automated component separators and integrated screening platforms, while parts of the Middle East and Africa focus investments on expanding basic collection and storage capabilities and improving access to essential reagents. These differences amplify the importance of supplier models that combine technology transfer, local training, and flexible commercial terms.

In the Asia-Pacific region, rapid healthcare infrastructure expansion, growing clinical demand, and targeted investments in biotechnology are driving increased uptake of advanced screening technologies and automated processing equipment. The region also presents a complex mix of centralized and decentralized procurement environments, with opportunities for manufacturers that can offer scalable solutions and localized service networks. Across all regions, local regulatory frameworks, donor demographics, and logistics considerations inform decisions on equipment standardization, reagent sourcing, and strategic partnerships.

How integrated product-service models and strategic partnerships are redefining competitive advantage for manufacturers and suppliers in the blood products sector

Competitive dynamics in the blood banking and blood products sector are increasingly defined by the integration of hardware, consumables, and software services into cohesive clinical solutions. Leading manufacturers are enhancing value propositions by coupling automated component separators and apheresis platforms with validated reagent portfolios and digital tools that streamline inventory management and donor traceability. Strategic alliances and targeted acquisitions are being used to fill capability gaps, accelerate entry into adjacent application areas, and strengthen service networks.

Companies that can demonstrate strong post-sale support, rapid access to consumables, and clear regulatory positioning hold a distinct advantage in procurement conversations. The ability to offer instrument-agnostic reagents and kits, backed by robust clinical validation, reduces switching costs for end users and opens cross-selling opportunities. In parallel, vendors emphasizing modularity and scalability in equipment design address the needs of both large centralized blood centers and smaller hospitals seeking predictable operational economics.

Service differentiation is also emerging through digital enablement, including analytics that optimize donor recruitment and component utilization, as well as remote diagnostics that reduce downtime and improve uptime guarantees. These capabilities are increasingly decisive in procurement evaluations, influencing long-term relationships and shaping the evolution of supplier landscapes.

Actionable leadership priorities that align procurement, interoperability, workforce development, and sourcing diversification to strengthen operational continuity

Industry leaders should prioritize investments that align technological capability with operational resilience and clinical safety imperatives. First, emphasize procurement strategies that balance long-term serviceability and consumable availability with initial capital efficiency, ensuring that equipment choices are supported by reliable post-sale service networks and validated reagent supplies. Second, advance interoperability by selecting platforms and vendors that support standardized data exchange and laboratory information system integration, thereby improving traceability and enabling more effective quality control.

Third, consider diversifying sourcing strategies to reduce exposure to single points of failure in global supply chains, including evaluating nearshoring options for critical reagents and consumables where feasible. Fourth, invest in workforce development and change management to ensure that the benefits of automation and new diagnostics translate into consistent clinical practice, focusing on competency frameworks and competency assessments. Fifth, prioritize participation in collaborative initiatives with regulators and peer institutions to harmonize testing standards and accelerate adoption of evidence-based screening protocols. These combined actions will strengthen operational continuity while enabling incremental adoption of high-impact technologies.

A layered research approach combining expert engagement, regulatory analysis, and technical evaluation to produce validated, operationally relevant insights

This research synthesis draws upon a layered methodology that integrates qualitative expert interviews, public regulatory documentation, peer-reviewed clinical literature, and primary supplier technical materials to create a comprehensive picture of current sector dynamics. Expert interviews were conducted with clinicians, laboratory directors, procurement specialists, and manufacturing technologists to surface practical constraints, adoption drivers, and implementation lessons across diverse operational settings. Public regulatory filings and guidance documents were analyzed to identify compliance requirements and evolving standards relevant to screening and transfusion safety.

Technical evaluation of equipment and reagents incorporated manufacturer specifications, independent validation studies, and where available, comparative performance assessments to illuminate trade-offs among throughput, sensitivity, and maintenance requirements. Operational implications were synthesized by mapping technology characteristics onto institutional workflows, enabling the development of actionable recommendations that are grounded in real-world constraints. Throughout, care was taken to ensure transparency of source types and to triangulate findings across multiple evidence streams to enhance reliability and relevance for decision-makers.

Consolidated conclusions emphasizing practical steps to translate technological advances and supply chain resilience into consistent clinical outcomes

The current environment for blood banking and blood products presents both challenges and tangible opportunities. Advances in diagnostic sensitivity, automation, and process integration are elevating standards for safety and efficiency, while geopolitical and trade developments underscore the need for resilient supply chains and flexible procurement models. Institutions that proactively align technology selection with serviceability, data interoperability, and workforce readiness will be better positioned to sustain high-quality transfusion services in the face of evolving clinical demands.

Moving forward, stakeholders should focus on pragmatic steps that reduce operational variability and enhance responsiveness, such as strengthening supplier relationships, expanding local capacity for critical consumables where possible, and investing in diagnostic platforms that balance accuracy with usability. The practical synthesis offered here is intended to support clear decision-making by executives, clinical leaders, and procurement professionals as they navigate a dynamic landscape that requires both immediate operational attention and strategic foresight.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Blood Banking & Blood Products Market, by Product Type

  • 8.1. Apheresis Equipment
    • 8.1.1. Leukapheresis
    • 8.1.2. Plasma Apheresis
    • 8.1.3. Platelet Apheresis
  • 8.2. Blood Collection And Storage Systems
    • 8.2.1. Double Blood Bag
    • 8.2.2. Quadruple Blood Bag
    • 8.2.3. Single Blood Bag
    • 8.2.4. Triple Blood Bag
  • 8.3. Blood Component Separators
    • 8.3.1. Automated Component Separators
    • 8.3.2. Manual Component Preparation Sets
  • 8.4. Blood Screening Tests
    • 8.4.1. Instruments
    • 8.4.2. Reagents And Kits
      • 8.4.2.1. Immunohematology Testing
      • 8.4.2.2. Infectious Disease Screening
      • 8.4.2.3. NAT Reagents
  • 8.5. Blood Transfusion Equipment
    • 8.5.1. Infusion Devices
    • 8.5.2. Warming Devices

9. Blood Banking & Blood Products Market, by Application

  • 9.1. Immunohematology
  • 9.2. Molecular Diagnostics
  • 9.3. Quality Control

10. Blood Banking & Blood Products Market, by End User

  • 10.1. Blood Banks And Donation Centers
  • 10.2. Diagnostic Laboratories
  • 10.3. Hospitals

11. Blood Banking & Blood Products Market, by Technology

  • 11.1. Flow Cytometry
  • 11.2. Nucleic Acid Amplification Technology
  • 11.3. Serological Testing

12. Blood Banking & Blood Products Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Blood Banking & Blood Products Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Blood Banking & Blood Products Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Blood Banking & Blood Products Market

16. China Blood Banking & Blood Products Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. American National Red Cross
  • 17.7. Asahi Kasei Corporation
  • 17.8. B. Braun Melsungen AG
  • 17.9. Becton, Dickinson and Company
  • 17.10. Bio-Rad Laboratories, Inc.
  • 17.11. Cardinal Health, Inc.
  • 17.12. CSL Limited
  • 17.13. Danaher Corporation
  • 17.14. F. Hoffmann-La Roche AG
  • 17.15. Fresenius SE & Co. KGaA
  • 17.16. Greiner Bio-One International GmbH
  • 17.17. Grifols, S.A.
  • 17.18. Haemonetics Corporation
  • 17.19. Immucor, Inc.
  • 17.20. Kedrion S.p.A.
  • 17.21. LFB S.A.
  • 17.22. Macopharma S.A.
  • 17.23. Medline Industries, Inc.
  • 17.24. Nipro Corporation
  • 17.25. Octapharma AG
  • 17.26. Ortho Clinical Diagnostics, Inc.
  • 17.27. QIAGEN N.V.
  • 17.28. Shandong Weigao Group Medical Polymer Co., Ltd.
  • 17.29. Takeda Pharmaceutical Company Limited
  • 17.30. Terumo Corporation
  • 17.31. Thermo Fisher Scientific Inc.
  • 17.32. Vitalant, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APHERESIS EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APHERESIS EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APHERESIS EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY LEUKAPHERESIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY LEUKAPHERESIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY LEUKAPHERESIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PLASMA APHERESIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PLASMA APHERESIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PLASMA APHERESIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PLATELET APHERESIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PLATELET APHERESIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PLATELET APHERESIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COLLECTION AND STORAGE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COLLECTION AND STORAGE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COLLECTION AND STORAGE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COLLECTION AND STORAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DOUBLE BLOOD BAG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DOUBLE BLOOD BAG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DOUBLE BLOOD BAG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY QUADRUPLE BLOOD BAG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY QUADRUPLE BLOOD BAG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY QUADRUPLE BLOOD BAG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SINGLE BLOOD BAG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SINGLE BLOOD BAG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SINGLE BLOOD BAG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TRIPLE BLOOD BAG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TRIPLE BLOOD BAG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TRIPLE BLOOD BAG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COMPONENT SEPARATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COMPONENT SEPARATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COMPONENT SEPARATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COMPONENT SEPARATORS, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY AUTOMATED COMPONENT SEPARATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY AUTOMATED COMPONENT SEPARATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY AUTOMATED COMPONENT SEPARATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY MANUAL COMPONENT PREPARATION SETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY MANUAL COMPONENT PREPARATION SETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY MANUAL COMPONENT PREPARATION SETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD SCREENING TESTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD SCREENING TESTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD SCREENING TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD SCREENING TESTS, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REAGENTS AND KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REAGENTS AND KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REAGENTS AND KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY IMMUNOHEMATOLOGY TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY IMMUNOHEMATOLOGY TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY IMMUNOHEMATOLOGY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY INFECTIOUS DISEASE SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY NAT REAGENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY NAT REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY NAT REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD TRANSFUSION EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD TRANSFUSION EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD TRANSFUSION EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD TRANSFUSION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY INFUSION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY INFUSION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY INFUSION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY WARMING DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY WARMING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY WARMING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY IMMUNOHEMATOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY IMMUNOHEMATOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY IMMUNOHEMATOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY QUALITY CONTROL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY QUALITY CONTROL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY QUALITY CONTROL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD BANKS AND DONATION CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD BANKS AND DONATION CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD BANKS AND DONATION CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY FLOW CYTOMETRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY FLOW CYTOMETRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY NUCLEIC ACID AMPLIFICATION TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SEROLOGICAL TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SEROLOGICAL TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SEROLOGICAL TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COLLECTION AND STORAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COMPONENT SEPARATORS, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD SCREENING TESTS, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD TRANSFUSION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COLLECTION AND STORAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COMPONENT SEPARATORS, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD SCREENING TESTS, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD TRANSFUSION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COLLECTION AND STORAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COMPONENT SEPARATORS, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD SCREENING TESTS, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD TRANSFUSION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COLLECTION AND STORAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COMPONENT SEPARATORS, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD SCREENING TESTS, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD TRANSFUSION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COLLECTION AND STORAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COMPONENT SEPARATORS, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD SCREENING TESTS, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD TRANSFUSION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COLLECTION AND STORAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COMPONENT SEPARATORS, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD SCREENING TESTS, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD TRANSFUSION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COLLECTION AND STORAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COMPONENT SEPARATORS, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD SCREENING TESTS, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD TRANSFUSION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COLLECTION AND STORAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COMPONENT SEPARATORS, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD SCREENING TESTS, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD TRANSFUSION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COLLECTION AND STORAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COMPONENT SEPARATORS, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD SCREENING TESTS, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD TRANSFUSION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 203. GCC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 204. GCC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. GCC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 206. GCC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COLLECTION AND STORAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 207. GCC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COMPONENT SEPARATORS, 2018-2032 (USD MILLION)
  • TABLE 208. GCC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD SCREENING TESTS, 2018-2032 (USD MILLION)
  • TABLE 209. GCC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 210. GCC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD TRANSFUSION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 211. GCC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 212. GCC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. GCC BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COLLECTION AND STORAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COMPONENT SEPARATORS, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD SCREENING TESTS, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD TRANSFUSION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COLLECTION AND STORAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COMPONENT SEPARATORS, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD SCREENING TESTS, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD TRANSFUSION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 236. G7 BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 237. G7 BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. G7 BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 239. G7 BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COLLECTION AND STORAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 240. G7 BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COMPONENT SEPARATORS, 2018-2032 (USD MILLION)
  • TABLE 241. G7 BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD SCREENING TESTS, 2018-2032 (USD MILLION)
  • TABLE 242. G7 BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 243. G7 BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD TRANSFUSION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 244. G7 BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 245. G7 BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 246. G7 BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 247. NATO BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 248. NATO BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. NATO BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 250. NATO BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COLLECTION AND STORAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 251. NATO BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COMPONENT SEPARATORS, 2018-2032 (USD MILLION)
  • TABLE 252. NATO BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD SCREENING TESTS, 2018-2032 (USD MILLION)
  • TABLE 253. NATO BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 254. NATO BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD TRANSFUSION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 255. NATO BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 256. NATO BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 257. NATO BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 258. GLOBAL BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COLLECTION AND STORAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COMPONENT SEPARATORS, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD SCREENING TESTS, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD TRANSFUSION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 270. CHINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. CHINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APHERESIS EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 273. CHINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COLLECTION AND STORAGE SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 274. CHINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD COMPONENT SEPARATORS, 2018-2032 (USD MILLION)
  • TABLE 275. CHINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD SCREENING TESTS, 2018-2032 (USD MILLION)
  • TABLE 276. CHINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY REAGENTS AND KITS, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY BLOOD TRANSFUSION EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 278. CHINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 279. CHINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA BLOOD BANKING & BLOOD PRODUCTS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)